1. Medtech Insight

Medtronic Builds Toward Integrated Care With A String Of Diabetes Deals

Medtronic inking four diabetes deals in about a month's time is no coincidence. The company wants to transform itself from a device maker that sells mostly to type 1 diabetics, into an integrated-care company that serves the broader diabetes community, and it does not have all the capabilities it needs to accomplish that feat in house, explains Hooman Hakami, who heads Medtronic's diabetes unit.

Over the next five years, Medtronic PLC has its eyes on becoming an integrated-care company for diabetes that serves 20 million patients, and events of the last month make clear that the medtech giant cannot accomplish this goal on its own.

Four deals in which Medtronic has partnered, invested or made an acquisition to advance its diabetes business have been announced since mid-March, and more transactions should be expected.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

More from Business